Filtros de búsqueda

Lista de obras de Thierry Poynard

A 1-year trial of telbivudine, lamivudine, and the combination in patients with hepatitis B e antigen-positive chronic hepatitis B

artículo científico publicado en 2005

A biphasic pattern of anti-pre-S responses in acute hepatitis B virus infection

artículo científico publicado en 1990

A comparison of fibrosis progression in chronic liver diseases

artículo científico publicado en 2003

A comparison of the fibrotic potential of nonalcoholic fatty liver disease and chronic hepatitis C

artículo científico publicado en 2010

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

artículo científico publicado en 1995

A constellation of cardiovascular risk factors is associated with hepatic enzyme elevation in hyperlipidemic patients

artículo científico publicado en 2002

A dose-ranging study of the efficacy and tolerability of entecavir in Lamivudine-refractory chronic hepatitis B patients

artículo científico publicado en 2005

A new 3p25 locus is associated with liver fibrosis progression in human immunodeficiency virus/hepatitis C virus-coinfected patients

artículo científico publicado en 2016

A novel dendritic cell subset involved in tumor immunosurveillance

artículo científico publicado en 2006

A prospective analysis of the prognostic value of biomarkers (FibroTest) in patients with chronic hepatitis C.

artículo científico publicado en 2006

A prospective assessment of an 'a la carte' regimen of PEG-interferon alpha2b and ribavirin combination in patients with chronic hepatitis C using biochemical markers

artículo científico publicado en 2006

A prospective assessment of the inter-laboratory variability of biochemical markers of fibrosis (FibroTest) and activity (ActiTest) in patients with chronic liver disease

artículo científico publicado en 2002

A prospective study of the evolution of lamivudine resistance mutations in patients with chronic hepatitis B treated with lamivudine

artículo científico publicado en 2006

A randomized trial of prednisolone in patients with severe alcoholic hepatitis

artículo científico publicado en 1992

A reference material for traceability of aspartate aminotransferase (AST) results

artículo científico publicado en 2005

A short induction regimen of interferon-alpha is not effective for treatment of relapse in chronic hepatitis C: a randomized trial. For the multicentre GER-CYT-01 group

artículo científico publicado en 1999

A simple biological index for detection of alcoholic liver disease in drinkers

artículo científico publicado en 1991

A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver

artículo científico

A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel

artículo científico publicado en 2011

Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and nonalcoholic patients: Localization and association with progression of liver fibrosis

Acetaldehyde-modified epitopes in liver biopsy specimens of alcoholic and nonalcoholic patients: Localization and association with progression of liver fibrosis

artículo científico publicado en 1994

Acoustic radiation force impulse imaging for evaluation of antiviral treatment response in chronic hepatitis C.

artículo científico publicado en 2012

ActiTest accuracy for the assessment of histological activity grades in patients with chronic hepatitis C, an overview using Obuchowski measure

artículo científico publicado en 2010

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.

artículo científico publicado en 2002

Adherence to pegylated combination therapy in patients with chronic hepatitis C. Importance of the hepatologist, general practitioner, and nurse

artículo científico publicado en 2008

Age and gender will survive to competing risks as fibrosis factors

artículo científico publicado en 2005

Age and platelet count: a simple index for predicting the presence of histological lesions in patients with antibodies to hepatitis C virus. METAVIR and CLINIVIR Cooperative Study Groups

artículo científico publicado en 1997

Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression

artículo científico publicado en 2009

Alpha-2-macroglobulin and hepatic fibrosis

scientific article published on 01 November 1994

An accurate definition of the status of inactive hepatitis B virus carrier by a combination of biomarkers (FibroTest-ActiTest) and viral load

artículo científico publicado en 2008

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

artículo científico publicado en 1996

An extension of STARD statements for reporting diagnostic accuracy studies on liver fibrosis tests: the Liver-FibroSTARD standards

artículo científico publicado en 2014

Analgesic effect of transcutaneous cranial electrostimulation in patients treated by Nd:YAG laser for cancer of the rectum. A double-blind randomized trial

artículo científico publicado el 1 de enero de 1992

Anti-hepatitis C virus antibody detection in oral fluid: influence of human immunodeficiency virus co-infection

artículo científico publicado en 2013

Anti-pre-S responses and viral clearance in chronic hepatitis B virus infection

artículo científico publicado en 1992

Anti-tumor necrosis factor-alpha therapy in severe alcoholic hepatitis: are large randomized trials still possible?

scientific article published on 01 April 2003

Antibiotic Prophylaxis for the Prevention of Bacterial Infections in Cirrhotic Patients with Ascites: A Meta-Analysis

article

Antibiotic prophylaxis for the prevention of bacterial infections in cirrhotic patients with gastrointestinal bleeding: a meta-analysis

artículo científico publicado en 1999

Anticardiolipin, anti-beta2-glycoprotein I, and antinucleosome antibodies in hepatitis C virus infection and mixed cryoglobulinemia. Multivirc Group

artículo científico publicado en 1997

Apolipoproteinemia A and α-fetoprotein in the diagnosis of hepatocellular carcinoma and cirrhosis: Several interpretations ⬇️

artículo científico publicado el 1 de mayo de 1990

Applicability and precautions of use of liver injury biomarker FibroTest. A reappraisal at 7 years of age

artículo científico publicado en 2011

Applicability and variability of liver stiffness measurements according to probe position

artículo científico publicado en 2009

Appropriate evidence-based data overviews demonstrate the diagnostic and prognostic performances of FibroTest in patients with chronic hepatitis C.

artículo científico publicado en 2009

Appropriateness of liver biopsy

artículo científico publicado en 2000

Assessing the outcome of nonalcoholic steatohepatitis? It's time to get serious

artículo científico publicado en 2006

Assessment of Liver Fibrosis and Steatosis in PBC With FibroScan, MRI, MR-spectroscopy, and Serum Markers

artículo científico publicado en 2010

Assessment of adrenal function in cirrhotic patients: salivary cortisol should be preferred

artículo científico publicado en 2010

Assessment of liver fibrosis and associated risk factors in HIV-infected individuals using transient elastography and serum biomarkers

artículo científico publicado en 2012

Assessment of liver fibrosis: noninvasive means

artículo científico publicado en 2008

Association between leptin, metabolic factors and liver histology in patients with chronic hepatitis C

artículo científico publicado en 2007

Awareness of the severity of liver disease re-examined using software-combined biomarkers of liver fibrosis and necroinflammatory activity.

artículo científico publicado en 2015

BRIP1 coding variants are associated with a high risk of hepatocellular carcinoma occurrence in patients with HCV- or HBV-related liver disease

artículo científico publicado en 2016

Baseline characteristics and early on-treatment response predict the outcomes of 2 years of telbivudine treatment of chronic hepatitis B.

artículo científico publicado en 2009

Beta-adrenergic-antagonist drugs in the prevention of gastrointestinal bleeding in patients with cirrhosis and esophageal varices. An analysis of data and prognostic factors in 589 patients from four randomized clinical trials. Franco-Italian Multic

artículo científico publicado en 1991

Biochemical markers of fibrosis in patients with chronic hepatitis C: a comparison with prothrombin time, platelet count, and age-platelet index

article

Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial

artículo científico publicado en 2002

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study

artículo científico publicado en 2001

Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C.

artículo científico publicado en 2002

Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa-2b and ribavirin

artículo científico publicado en 2003

Biological markers of liver fibrosis and activity as non-invasive alternatives to liver biopsy in patients with chronic hepatitis C and associated mixed cryoglobulinemia vasculitis

artículo científico publicado en 2006

Biomarkers for the prediction of liver fibrosis in patients with chronic alcoholic liver disease

artículo científico publicado en 2005

Biomarkers of liver fibrosis

artículo científico publicado en 2008

Biomarkers of liver injury for hepatitis clinical trials: a meta-analysis of longitudinal studies

artículo científico publicado en 2010

Blood neutrophil functions and cytokine release in severe alcoholic hepatitis: effect of corticosteroids

scientific article published on 01 April 2000

Blood oxidative stress markers are unreliable markers of hepatic steatosis

artículo científico publicado en 2006

CagA status and virulence of Helicobacter pylori strains. Results of a French multicentric prospective study

artículo científico publicado en 2001

Can nonalcoholic steatohepatitis be diagnosed without liver biopsy?

artículo científico publicado en 2009

Candidate biomarkers for the diagnosis and prognosis of drug-induced liver injury: An international collaborative effort

artículo científico publicado en 2018

Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV International Panel.

artículo científico publicado en 2002

Chapter 4 Biomarkers Of Liver Fibrosis

Chronic hepatitis B treatment with lamivudine in kidney transplant patients

scientific article published on 01 December 2000

Chronic hepatitis C virus (HCV) disease burden and cost in the United States

artículo científico publicado en 2013

Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin

artículo científico publicado en 2017

Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective.

artículo científico publicado en 2018

Cirrhosis as an independent risk factor for colonic adenomas ⬇️

artículo científico publicado el 1 de abril de 1992

Clonal B cell populations in the blood and liver of patients with chronic hepatitis C virus infection

artículo científico publicado en 2004

Coexistence of circulating HBsAg and anti-HBs antibodies in chronic hepatitis B carriers is not a simple analytical artifact and does not influence HBsAg quantification

artículo científico publicado en 2014

Coexistence of hepatitis B surface antigen (HBs Ag) and anti-HBs antibodies in chronic hepatitis B virus carriers: influence of "a" determinant variants

artículo científico publicado en 2006

Combination therapy with interferon plus ribavirin for the initial treatment of chronic hepatitis C.

artículo científico publicado en 1999

Comparing the public health burden of chronic hepatitis C and HIV infection in France

artículo científico publicado en 2004

Comparison of acoustic radiation force impulse imaging with transient elastography for the detection of complications in patients with cirrhosis

artículo científico publicado en 2011

Comparison of bathophenanthroline sulfonate and ferene as chromogens in colorimetric measurement of low hepatic iron concentration.

artículo científico publicado en 2001

Comparison of elastography, serum marker scores, and histology for the assessment of liver fibrosis in hepatitis B virus (HBV)-infected patients in Burkina Faso

artículo científico publicado en 2010

Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study

artículo científico publicado en 2002

Concordance in a world without a gold standard: a new non-invasive methodology for improving accuracy of fibrosis markers

artículo científico publicado en 2008

Continuous infusion of high-dose omeprazole is more effective than standard-dose omeprazole in patients with high-risk peptic ulcer bleeding: a retrospective study

artículo científico publicado en 2007

Correction: An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load

artículo científico publicado en 2008

Correlation between hepatitis C virus prevalence and hepatocellular carcinoma mortality in Europe

artículo científico publicado en 1999

Corrigendum to “Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C” [J Hepatol 36 (2002) 812–818]

scholarly article published in Journal of Hepatology

Corrigendum to: “FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC3 program” [J Hepatol 2011;54:227–235]

scholarly article published in Journal of Hepatology

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis (AH): individual data analysis of the last three randomized placebo controlled double blind trials of corticosteroids in severe AH.

artículo científico publicado en 2002

Cost effectiveness of pegylated interferon alpha 2b and ribavirin combination in chronic hepatitis C.

artículo científico publicado en 2003

Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.

artículo científico publicado en 2011

Cost-effectiveness of 24 or 48 weeks of interferon alpha-2b alone or with ribavirin as initial treatment of chronic hepatitis C. International Hepatitis Interventional Therapy Group

artículo científico publicado en 2000

Critical comparison of elastography methods to assess chronic liver disease

artículo científico publicado en 2016

Cystic Fibrosis Related Liver Disease: Research Challenges and Future Perspectives

artículo científico publicado en 2017

Decreased frequencies of virus-specific T helper type 1 cells during interferon alpha plus ribavirin treatment in HIV-hepatitis C virus co-infection

artículo científico publicado en 2004

Definition of an HBsAg to DNA international unit conversion factor by enrichment of circulating hepatitis B virus forms

artículo científico publicado en 2015

Diagnosis and treatment of viral liver fibrosis

artículo científico publicado en 2005

Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease

artículo científico publicado en 2009

Diagnostic performance of FibroTest, SteatoTest and ActiTest in patients with NAFLD using the SAF score as histological reference

artículo científico publicado en 2016

Diagnostic performance of a new noninvasive test for nonalcoholic steatohepatitis using a simplified histological reference.

artículo científico publicado en 2018

Diagnostic value of FibroTest with normal serum aminotransferases

artículo científico publicado en 2006

Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2006

Diagnostic value of biochemical markers (NashTest) for the prediction of non alcoholo steato hepatitis in patients with non-alcoholic fatty liver disease

artículo científico publicado en 2006

Diagnostic value of serum gamma-glutamyl-transferase activity and mean corpuscular volume in alcoholic patients with or without cirrhosis

artículo científico publicado en 1990

Diagnostic value of serum protein profiling by SELDI-TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C.

artículo científico publicado en 2007

Discordance between results of biomarkers of fibrosis shows that it is at least a “ménage à deux”

artículo científico publicado en 2009

Do the interferons have an antifibrotic action? The hepatologist's point of view

artículo científico publicado en 2002

Does elective sclerotherapy improve the efficacy of long-term propranolol for prevention of recurrent bleeding in patients with severe cirrhosis? A prospective multicenter, randomized trial

artículo científico publicado en 1992

Early Use of TIPS for Cirrhosis and Variceal Bleeding ⬇️

artículo científico publicado el 30 de septiembre de 2010

Editorial: simplifying screening for primary liver cancer - do the LCR1 and LCR2 tests hold the key? Authors' reply

scientific article published on 01 March 2019

Effect of interferon therapy on the natural history of hepatitis C virus-related cirrhosis and hepatocellular carcinoma

artículo científico publicado en 1999

Effect of prolonged interferon therapy on the outcome of hepatitis C virus-related cirrhosis: a randomized trial

artículo científico publicado en 2007

Effect of terlipressin (Glypressin) on hepatorenal syndrome in cirrhotic patients: results of a multicentre pilot study

artículo científico publicado en 2002

Effect of treatment with peginterferon or interferon alfa-2b and ribavirin on steatosis in patients infected with hepatitis C.

artículo científico publicado en 2003

Effectiveness of interferon plus ribavirin combination in the treatment of naive patients with hepatitis C virus type 5. A French multicentre retrospective study

artículo científico publicado en 2006

Effectiveness of telaprevir or boceprevir in treatment-experienced patients with HCV genotype 1 infection and cirrhosis

artículo científico publicado en 2014

Effects of cirrhosis, interferon and azathioprine on adverse events in patients with chronic hepatitis C treated with ribavirin ⬇️

artículo científico publicado el 1 de julio de 1997

Effects of interferon therapy in "non responder" patients with chronic hepatitis C.

artículo científico publicado en 1999

Effects of lamivudine on replication of hepatitis B virus in HIV-infected men.

artículo científico publicado en 1996

Efficacy and Safety of Sofosbuvir Plus Daclatasvir for Treatment of HCV-Associated Cryoglobulinemia Vasculitis

artículo científico publicado en 2017

Efficacy and safety of adefovir dipivoxil plus pegylated interferon-alpha2a for the treatment of lamivudine-resistant hepatitis B virus infection in HIV-infected patients.

artículo científico publicado en 2008

Efficacy of lamivudine on replication of hepatitis B virus in HIV-infected patients

artículo científico publicado en 1995

Efficiency of respiratory assistance in cirrhotic patients with liver failure.

artículo científico publicado en 1983

Elevated levels of circulating CDH5 and FABP1 in association with human drug-induced liver injury

artículo científico publicado en 2016

Endoscopic Nd-YAG laser therapy as palliative treatment for esophageal and cardial cancer. Parameters affecting long-term outcome

artículo científico publicado en 1990

Endoscopic hemostasis for hemorrhagic gastroduodenal ulcer. Meta-analysis of randomized clinical trials

artículo científico publicado el 1 de enero de 1991

Endoscopic laser therapy for duodenal villous adenoma

artículo científico publicado en 1989

Epidemiology and methodology of randomized therapeutic trials in patients with intestinal functional disorders

artículo científico publicado en 1990

Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States

artículo científico publicado en 2007

Ethanol-induced inhibition of cytokine release and protein degranulation in human neutrophils

artículo científico publicado en 2002

Evaluation of FibroTest inter-laboratory variations requires standardization on analytical systems and should not be mixed with underpowered histological validation

Evaluation of FibroTest-ActiTest in children with chronic hepatitis C virus infection

artículo científico publicado en 2009

Evaluation of efficacy of liver transplantation in alcoholic cirrhosis by a case-control study and simulated controls

artículo científico publicado en 1994

Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival

artículo científico publicado en 1999

Evaluation of hepatitis B vaccination in a Paris hospital personnel. 386 subjects

artículo científico publicado en 1987

Evolution of biomarkers of liver fibrosis and liver insufficiency in hepatitis C virus-infected patients treated with pegylated interferon plus ribavirin and rituximab.

artículo científico publicado en 2012

Expression of histocompatibility antigens and characterization of the lymphocyte infiltrate in hyperplastic polyps of the large bowel

artículo científico publicado en 1990

Extrahepatic manifestations of chronic hepatitis C. MULTIVIRC Group. Multidepartment Virus C.

artículo científico publicado en 1999

FAS promoter polymorphisms correlate with activity grade in hepatitis C patients

artículo científico publicado en 2005

Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy

artículo científico publicado en 2001

Factors associated with serum alanine transaminase activity in healthy subjects: consequences for the definition of normal values, for selection of blood donors, and for patients with chronic hepatitis C. MULTIVIRC Group

artículo científico publicado en 1998

Factors that predict response of patients with hepatitis C virus infection to boceprevir

artículo científico publicado en 2012

Factors to improve the management of hepatitis C in drug users: an observational study in an addiction centre

artículo científico publicado en 2010

Fat, diabetes, and liver injury in chronic hepatitis C.

artículo científico publicado en 2004

Fatigue in patients with chronic hepatitis C.

artículo científico publicado en 2002

Fatty liver is an independent predictor of early carotid atherosclerosis

artículo científico publicado en 2016

Faut-il encore faire des biopsies du foie ?

artículo científico publicado en 2006

FibroMAX: towards a new universal biomarker of liver disease?

artículo científico publicado en 2007

FibroStic: a large confirmatory study for non-invasive biomarkers accuracy, if correctly interpreted

artículo científico publicado en 2011

FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C.

artículo científico publicado en 2008

FibroTest is an independent predictor of virologic response in chronic hepatitis C patients retreated with pegylated interferon alfa-2b and ribavirin in the EPIC³ program

artículo científico publicado en 2010

FibroTest is effective in patients with normal transaminases, when accuracy is standardized on fibrosis stage prevalence

artículo científico publicado en 2008

FibroTest-ActiTest as a non-invasive marker of liver fibrosis

artículo científico publicado en 2008

FibroTest-FibroSURE™: towards a universal biomarker of liver fibrosis?

scientific article published on 01 January 2005

FibroTest® and Fibroscan® performances revisited in patients with chronic hepatitis C. Impact of the spectrum effect and the applicability rate

article

Fibrogenic impact of high serum glucose in chronic hepatitis C.

artículo científico publicado en 2003

Fibrosis as an end point for clinical trials in liver disease: a report of the international fibrosis group

artículo científico publicado en 2006

Fibrosis in patients with chronic hepatitis C: detection and significance

artículo científico publicado en 2000

First-line assessment of patients with chronic liver disease with non-invasive techniques and without recourse to liver biopsy ⬇️

artículo científico publicado el 14 de octubre de 2010

Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis

artículo científico publicado en 2002

Focal nodular hyperplasia of the liver on ferumoxides-enhanced MR imaging: features on conventional spin-echo, fast spin-echo and gradient-echo pulse sequences

artículo científico publicado en 1999

Gastric mucormycosis: A rare cause of gastrointestinal bleeding in cirrhosis

scientific article published on 03 December 2011

Gastric phytobezoar destruction by Nd:YAG laser therapy

artículo científico publicado en 1986

Gemcitabine plus oxaliplatin (GEMOX) combined with cetuximab in patients with progressive advanced stage hepatocellular carcinoma: results of a multicenter phase 2 study

artículo científico publicado en 2008

Gemcitabine plus oxaliplatin (GEMOX) in patients with advanced hepatocellular carcinoma (HCC): results of a phase II study

artículo científico publicado en 2007

Gemcitabine plus oxaliplatin for patients with advanced hepatocellular carcinoma using two different schedules

artículo científico publicado en 2003

Gene expression profiles of bladder cancers: evidence for a striking effect of in vitro cell models on gene patterns

artículo científico publicado en 2002

Gene transfer in hepatocarcinoma cell lines: in vitro optimization of a virus-free system.

artículo científico publicado en 1996

Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection

artículo científico publicado en 2012

HCV-GenoFibrotest: A combination of viral, liver and genomic (IL28b, ITPA, UGT1A1) biomarkers for predicting treatment response in patients with chronic hepatitis C ⬇️

artículo científico publicado el 26 de febrero de 2011

Hepatic HCV RNA before and after treatment with interferon alone or combined with ribavirin

artículo científico publicado en 2002

Hepatitis B virus (HBV) mutations associated with resistance to lamivudine in patients coinfected with HBV and human immunodeficiency virus

artículo científico publicado en 1999

Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease?

artículo científico publicado en 2006

Hepatitis C: somber views of natural history and optimistic views of interferon treatment?

artículo científico publicado en 1998

Hepatitis E infection in patients with severe alcoholic hepatitis: is there a place for systematic screening?

artículo científico publicado en 2015

Hepatitis b vaccine: a diagnostic test for previous hepatitis B virus infection? ⬇️

artículo científico publicado el 21 de abril de 1984

Hepatotoxicity of metastatic colorectal cancer chemotherapy: systematic review

artículo científico publicado en 2010

High rate of adefovir-lamivudine combination therapy in nucleoside-naïve patients with chronic hepatitis B in France: results of a national survey in 1730 patients

artículo científico publicado en 2010

High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats

scientific journal article

Hirsch index and truth survival in clinical research

artículo científico publicado en 2010

Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability

artículo científico publicado en 2007

IL28B alleles associated with poor hepatitis C virus (HCV) clearance protect against inflammation and fibrosis in patients infected with non-1 HCV genotypes

artículo científico publicado en 2011

Identification of an Endoglin Variant Associated With HCV-Related Liver Fibrosis Progression by Next-Generation Sequencing

artículo científico publicado en 2019

Immediate listing for liver transplantation versus standard care for Child-Pugh stage B alcoholic cirrhosis: a randomized trial

artículo científico publicado en 2009

Immune suppression as the etiology of failure to detect anti-HBc antibodies in patients with chronic hepatitis B virus infection

artículo científico publicado en 2006

Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest-ActiTest) in patients infected by hepatitis B virus

artículo científico publicado en 2008

Impact of common risk factors of fibrosis progression in chronic hepatitis C.

artículo científico publicado en 2014

Impact of hepatitis B and C virus on kidney transplantation outcome

artículo científico publicado en 1999

Impact of human immunodeficiency virus infection on the histological features of chronic hepatitis C: a case-control study. The MULTIVIRC group

artículo científico publicado en 2000

Impact of interferon alfa-2b and ribavirin on progression of liver fibrosis in patients with chronic hepatitis C.

artículo científico publicado en 2000

Impact of interferon-alpha treatment on liver fibrosis in patients with chronic hepatitis B: an overview of published trials

artículo científico publicado en 2009

Impact of irritable bowel syndrome (IBS) on health-related quality of life (HRQOL).

artículo científico publicado en 2006

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

artículo científico publicado en 2002

Impact of steatosis and inflammation definitions on the performance of NASH tests.

artículo científico publicado en 2018

Impact of treatment on extra hepatic manifestations in patients with chronic hepatitis C.

artículo científico publicado en 2002

Improved inflammatory activity with peginterferon alfa-2b maintenance therapy in non-cirrhotic prior non-responders: A randomized study

In situ detection of lipid peroxidation by-products in chronic liver diseases

artículo científico publicado en 1997

In situ detection of lipid peroxidation in chronic hepatitis C: correlation with pathological features

scientific article published on May 1997

In vitro susceptibility of lamivudine-resistant hepatitis B virus to adefovir and tenofovir.

artículo científico publicado en 2004

Independent risk factors for hepatocellular carcinoma in French drinkers

artículo científico publicado en 1991

Individual and evidence-based

artículo científico publicado en 2002

Influence of interferon-based therapy on liver fibrosis progression in HIV/HCV coinfected patients: a retrospective repeated liver biopsy analysis

artículo científico publicado en 2011

Influence of the HCV subtype on the virological response to pegylated interferon and ribavirin therapy

artículo científico publicado en 2009

Interferon for acute hepatitis C.

artículo científico publicado en 2002

Interferon for interferon naive patients with chronic hepatitis C.

artículo científico publicado en 2002

Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.

artículo científico publicado en 2002

Interferon gamma receptor 2 gene variants are associated with liver fibrosis in patients with chronic hepatitis C infection

artículo científico publicado en 2010

Interferon-gamma with peginterferon alpha-2a and ribavirin in nonresponder patients with chronic hepatitis C (ANRS HC16 GAMMATRI).

artículo científico publicado en 2013

Interleukin-28B polymorphism improves viral kinetics and is the strongest pretreatment predictor of sustained virologic response in genotype 1 hepatitis C virus

artículo científico publicado en 2010

Intermethod calibration of alanine aminotransferase (ALT) and γ-glutamyltransferase (GGT) results: application to Fibrotest® and Actitest® scores

artículo científico publicado en 2006

Intestinal functional disorders: review of the literature

artículo científico publicado en 1977

Intra-individual fasting versus postprandial variation of biochemical markers of liver fibrosis (FibroTest) and activity (ActiTest)

artículo científico publicado en 2004

Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors

artículo científico publicado en 2004

Intra-laboratory analytical variability of biochemical markers of fibrosis (Fibrotest) and activity (Actitest) and reference ranges in healthy blood donors

article published in 2004

Intrahepatic virus-specific IL-10-producing CD8 T cells prevent liver damage during chronic hepatitis C virus infection

artículo científico publicado en 2006

Invasive pulmonary aspergillosis in patients with decompensated cirrhosis: case series

artículo científico publicado en 2007

Irinotecan as first-line chemotherapy in patients with advanced hepatocellular carcinoma: a multicenter phase II study with dose adjustment according to baseline serum bilirubin level

artículo científico publicado en 2006

Is an "a la carte" combination interferon alfa-2b plus ribavirin regimen possible for the first line treatment in patients with chronic hepatitis C? The ALGOVIRC Project Group

artículo científico publicado en 2000

Is antiviral treatment (IFN alpha and/or ribavirin) justified in cirrhosis related to hepatitis C virus? Société Royale Belge de Gastro-entérologie

artículo científico publicado en 1998

LCR1 and LCR2, two multi-analyte blood tests to assess liver cancer risk in patients without or with cirrhosis

artículo científico publicado en 2018

Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis

article published in 1999

Lack of effect of propranolol in the prevention of large oesophageal varices in patients with cirrhosis: a randomized trial. French-Speaking Club for the Study of Portal Hypertension

article

Lamivudine and HBV-associated nephropathy

artículo científico publicado en 2005

Laparoscopic treatment without cholecystectomy for gallbladder perforation after liver biopsy

artículo científico publicado en 1993

Letter: FibroTest for staging fibrosis in non-alcoholic fatty liver disease

artículo científico publicado en 2013

Liver biopsy analysis has a low level of performance for diagnosis of intermediate stages of fibrosis

artículo científico publicado en 2012

Liver biopsy: The best standard…when everything else fails

artículo científico publicado en 2009

Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy

artículo científico publicado en 2009

Liver fibrosis evaluation using real-time shear wave elastography: applicability and diagnostic performance using methods without a gold standard

artículo científico publicado en 2013

Liver fibrosis in overweight patients

artículo científico publicado en 2000

Liver fibrosis in viral hepatitis: noninvasive assessment with acoustic radiation force impulse imaging versus transient elastography

artículo científico publicado en 2009

Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group

artículo científico publicado en 1999

Liver stiffness is an unreliable marker of liver fibrosis in patients with cardiac insufficiency

artículo científico publicado en 2008

Liver stiffness, platelets, and spleen size is reliable in nondecompensated cirrhotic patients

artículo científico publicado en 2013

Liver-FibroSTARD checklist and glossary: tools for standardized design and reporting of diagnostic accuracy studies of liver fibrosis tests

Localization of apolipoprotein A-I and apolipoprotein A-II in human atherosclerotic arteries

artículo científico publicado en 1989

Long-Term Efficacy of Interferon-Free Antiviral Treatment Regimens in Patients With Hepatitis C Virus–Associated Cryoglobulinemia Vasculitis

Long-term clearance of hepatitis C virus following interferon α-2b or peginterferon α-2b, alone or in combination with ribavirin.

artículo científico publicado en 2013

Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial

artículo científico publicado en 2010

Long-term impact of renal transplantation on liver fibrosis during hepatitis C virus infection

artículo científico publicado en 2002

Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients

artículo científico publicado en 1999

Long-term outcome improvement in patients with chronic hepatitis D treated with interferon α

scientific article published on 01 December 2004

Long-term prognostic value of the FibroTest in patients with non-alcoholic fatty liver disease, compared to chronic hepatitis C, B, and alcoholic liver disease

artículo científico publicado en 2018

Long-term results of treatment of vascular malformations of the gastrointestinal tract by neodymium YAG laser photocoagulation

artículo científico publicado en 1990

Long-term therapy with lamivudine in renal transplant recipients with chronic hepatitis B.

artículo científico publicado en 2004

Longitudinal assessment of histology surrogate markers (FibroTest-ActiTest) during lamivudine therapy in patients with chronic hepatitis B infection.

artículo científico publicado en 2005

Longterm course of mixed cryoglobulinemia in patients infected with hepatitis C virus

artículo científico publicado en 2004

Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis

artículo científico publicado en 2011

Low 25-hydroxyvitamin D serum levels correlate with the presence of extra-hepatic manifestations in chronic hepatitis C virus infection

artículo científico publicado en 2012

Low hepatic iron concentration: evaluation of two complementary methods, colorimetric assay and iron histological scoring

artículo científico publicado en 1999

Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection

artículo científico publicado en 2003

Maintenance therapy with peginterferon alfa-2b does not prevent hepatocellular carcinoma in cirrhotic patients with chronic hepatitis C.

artículo científico publicado en 2011

Management of hepatitis C

artículo científico publicado en 1998

Marked increase in serum CA 19-9 level in patients with alcoholic cirrhosis: report of four cases.

artículo científico publicado en 1996

Meta-analyses of FibroTest diagnostic value in chronic liver disease

artículo científico publicado en 2007

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C in naive patients: 1999 Update

article

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: Effects of dose and duration

article

Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration

scientific article published on 01 October 1996

Meta-analysis of randomized clinical trials comparing lansoprazole with ranitidine or famotidine in the treatment of acute duodenal ulcer.

artículo científico publicado en 1995

Meta-analysis of smooth muscle relaxants in the treatment of irritable bowel syndrome

artículo científico publicado en 2001

Meta-analysis: a tool for clinical Hepato-Gastroenterology

artículo científico publicado en 1991

Metformin reduces post-prandial insulin needs in type I (insulin-dependent) diabetic patients: Assessment by the artificial pancreas

artículo científico publicado en 1982

Methodological aspects of the interpretation of non-invasive biomarkers of liver fibrosis: a 2008 update

artículo científico publicado en 2008

Methodological problems of randomized clinical trials in the treatment of duodenal ulcer, "gastritis" and Campylobacter pylori infection

artículo científico publicado en 1989

Model for end-stage liver disease score and systemic inflammatory response are major prognostic factors in patients with cirrhosis and acute functional renal failure

article

Modeling the hepatitis C virus epidemic in France

artículo científico publicado en 1999

Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group

artículo científico publicado en 1999

Mucosa-associated lyphoid tissue hepatic lymphoma with low-grade malignancy associated with primary biliary cirrhosis

artículo científico publicado en 2003

Multicentre study of hepatitis B virus genotypes in France: correlation with liver fibrosis and hepatitis B e antigen status.

artículo científico publicado en 2006

Multivariate analysis of prognostic factors in fulminant hepatitis B.

artículo científico publicado en 1986

NAFLD and liver transplantation: Current burden and expected challenges

artículo científico publicado en 2016

NASH: a hidden and silent fibroser finally revealed?

artículo científico publicado en 2005

NNRTI-related or -unrelated hepatotoxicity?

article

Nadolol for prophylaxis of gastrointestinal bleeding in patients with cirrhosis. A randomized trial

artículo científico publicado en 1988

Natural history and predictors of disease severity in chronic hepatitis C.

artículo científico publicado en 2005

Natural history of HCV infection

artículo científico publicado en 2000

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

artículo científico publicado en 1997

Natural variability of NS3 protease in patients infected with genotype 4 hepatitis C virus (HCV): implications for antiviral treatment using specifically targeted antiviral therapy for HCV.

artículo científico publicado en 2009

No evidence for abnormal immune activation in peripheral blood T cells in patients with hepatitis C virus (HCV) infection with or without cryoglobulinaemia. Multivirc Group

artículo científico publicado en 1998

Nodular regenerative hyperplasia: The main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities

artículo científico publicado en 2007

Non-invasive diagnosis of large oesophageal varices with FibroTest in patients with cirrhosis: a preliminary retrospective study

artículo científico publicado en 2006

Non-invasive measurement of liver and pancreas fibrosis in patients with cystic fibrosis

artículo científico publicado en 2013

Nonalcoholic fatty liver disease increases the risk of hepatocellular carcinoma in patients with alcohol-associated cirrhosis awaiting liver transplants

artículo científico publicado en 2014

Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B.

artículo científico publicado en 2011

Noninvasive assessment of liver fibrosis in patients with Fontan circulation using transient elastography and biochemical fibrosis markers

artículo científico publicado en 2008

Noninvasive biomarkers for the screening of fibrosis, steatosis and steatohepatitis in patients with metabolic risk factors: FibroTest-FibroMax experience.

artículo científico publicado en 2008

Noninvasive prediction of fibrosis in patients with chronic hepatitis C

article

O.116 Reasons for the lack of anti-HBC antibody detection in hepatitis B virus chronically infected patients

article by V. Avettand-Fenoel et al published January 2006 in Journal of Clinical Virology

Optimal correlation between different instruments for Fibrotest-Actitest protein measurement in patients with chronic hepatitis C.

artículo científico publicado en 2007

Optimal nonsurgical management of peptic ulcer bleeding, including arterial embolization is associated with a mortality below 1%.

artículo científico publicado en 2012

Overview of the diagnostic value of biochemical markers of liver fibrosis (FibroTest, HCV FibroSure) and necrosis (ActiTest) in patients with chronic hepatitis C

artículo científico publicado en 2004

Palliative treatment of adenocarcinoma of the rectum by Nd-YAG laser. Immediate and long-term results. Study of factors related to the initial destruction of the tumor

artículo científico publicado en 1986

Palliative treatment of cancers of the esophagus and cardia with YAG neodymium laser. (Preliminary noncontrolled trial)

artículo científico publicado en 1984

Peginterferon alfa-2b and ribavirin: effective in patients with hepatitis C who failed interferon alfa/ribavirin therapy

artículo científico publicado en 2009

Pegylated interferon alpha 2b and ribavirin in HIV/hepatitis C virus-co-infected non-responders and relapsers to IFN-based therapy

artículo científico publicado en 2004

Pentoxifylline does not decrease short-term mortality but does reduce complications in patients with advanced cirrhosis

artículo científico publicado en 2010

Peptic ulcer bleeding in patients with or without cirrhosis: different diseases but the same prognosis?

artículo científico publicado en 2012

Performance of biomarkers FibroTest, ActiTest, SteatoTest, and NashTest in patients with severe obesity: meta analysis of individual patient data

artículo científico publicado en 2012

Performance of serum apolipoprotein-A1 as a sentinel of Covid-19

artículo científico publicado en 2020

Performance of the FibroTest cannot be accurately estimated in nine paediatric patients with advanced fibrosis

article

Performances of Elasto-FibroTest(®), a combination between FibroTest(®) and liver stiffness measurements for assessing the stage of liver fibrosis in patients with chronic hepatitis C.

artículo científico publicado en 2012

Perioperative management of combined heart-liver transplantation in patients with cirrhosis, renal insufficiency, or pulmonary hypertension

artículo científico publicado en 2011

Perspectives on fibrosis progression in hepatitis C: an à la carte approach to risk factors and staging of fibrosis

artículo científico publicado en 2010

Point Shear Wave Elastography by Acoustic Radiation Force Impulse Quantification in Comparison to Transient Elastography for the Noninvasive Assessment of Liver Fibrosis in Chronic Hepatitis C: A Prospective International Multicenter Study

artículo científico publicado en 2015

Polymorphonuclear neutrophils are a source of hepatocyte growth factor in patients with severe alcoholic hepatitis

artículo científico publicado en 2002

Portal lymphocytic infiltrate in alcoholic liver disease

artículo científico publicado en 2002

Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B

article

Prediction of oesophageal varices with platelet count/spleen diameter ratio or platelets alone.

artículo científico publicado en 2004

Predictive value of ALT levels for histologic findings in chronic hepatitis C: a European collaborative study

artículo científico publicado en 2002

Prednisone-interferon combination in the treatment of chronic hepatitis B: direct and indirect metanalysis.

artículo científico publicado en 1994

Prevalence of Cholelithiasis According to Alcoholic Liver Disease: A Possible Role of Apolipoproteins AI and AII

artículo científico publicado en 1995

Prevalence of irritable bowel syndrome (IBS) and variability of diagnostic criteria.

artículo científico publicado en 2004

Prevalence of liver fibrosis and risk factors in a general population using non-invasive biomarkers (FibroTest)

artículo científico publicado en 2010

Prevalence of serum anti-hepatitis C virus antibodies and risk factors of contamination in the personnel of a hospital in the Paris region. A prospective survey

artículo científico publicado en 1996

Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease

artículo científico publicado en 2014

Prognosis of treated severe alcoholic hepatitis in patients with gastrointestinal bleeding

artículo científico publicado en 2014

Prognostic value of liver fibrosis biomarkers: a meta-analysis.

artículo científico publicado en 2011

Prognostic value of serum fibronectin concentration in alcoholic cirrhotic patients

scientific article published on 01 September 1985

Prognostic value of total serum bilirubin/gamma-glutamyl transpeptidase ratio in cirrhotic patients.

artículo científico publicado en 1984

Progression from isolated steatosis to steatohepatitis and fibrosis in nonalcoholic fatty liver disease

artículo científico publicado en 2011

Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure.

artículo científico publicado en 2004

Prolonged therapy for hepatitis C with low-dose peginterferon.

artículo científico publicado en 2009

Prolonged treatment with interferon in patients with histologically mild chronic hepatitis C: a decision analysis

scientific article published on 01 September 1998

Propranolol and sclerotherapy in the prevention of gastrointestinal rebleeding in patients with cirrhosis: a meta-analysis

article

Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a controlled study

artículo científico publicado en 1981

Propranolol for prevention of recurrent gastrointestinal bleeding in patients with cirrhosis: a prospective study of factors associated with rebleeding

artículo científico publicado en 1987

Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C.

artículo científico publicado en 2004

Psoriasis, alcohol, and liver disease

artículo científico publicado en 1985

Quantification of apolipoprotein A-I and B messenger RNA in heavy drinkers according to liver disease

artículo científico publicado en 1996

Quantification of fibrosis progression in patients with chronic hepatitis C using a Markov model

artículo científico publicado en 2002

Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease

artículo científico publicado en 1998

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

artículo científico publicado en 1998

Randomized double-blind clinical trial of aluminum phosphate versus ranitidine in the acute treatment of duodenal ulcer

artículo científico publicado en 1990

Randomized therapeutic trials in intestinal functional disorders

artículo científico publicado en 1990

Randomized, multicentre comparison of sodium alginate and cisapride in the symptomatic treatment of uncomplicated gastro-oesophageal reflux

artículo científico publicado en 1998

Ranking hepatologists: which Hirsch's h-index to prevent the "e-crise de foi-e"?

artículo científico publicado en 2011

Rate of employment after liver transplantation in France: a single-centre study

artículo científico publicado en 2015

Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis c.

artículo científico publicado en 2001

Real time identification of drug-induced liver injury (DILI) through daily screening of ALT results: a prospective pilot cohort study

artículo científico publicado en 2012

Real-Time Shear Wave versus Transient Elastography for Predicting Fibrosis: Applicability, and Impact of Inflammation and Steatosis. A Non-Invasive Comparison.

artículo científico publicado en 2016

Recombinant activated factor VII in chronic liver diseases: Should we be afraid of thromboembolic events?

artículo científico publicado en 2011

Recurrent bleeding and propranolol?

scientific article published on 01 July 1983

Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial

artículo científico publicado en 2003

Relationship between degree of portal hypertension and liver histologic lesions in patients with alcoholic cirrhosis. Effect of acute alcoholic hepatitis on portal hypertension.

artículo científico publicado en 1987

Relationship between mean corpuscular volume, alcohol consumption, smoking habits, and alcoholic liver disease in hospitalized patients (author's transl)

artículo científico publicado el 1 de marzo de 1979

Relationship between the Fibrotest and portal hypertension in patients with liver disease

scientific article published on 01 August 2007

Relationships between liver histologic lesions and portal hypertension in patients with alcoholic cirrhosis

Relative performances of FibroTest, Fibroscan, and biopsy for the assessment of the stage of liver fibrosis in patients with chronic hepatitis C: A step toward the truth in the absence of a gold standard

article

Replication status and histological features of patients with triple (B, C, D) and dual (B, C) hepatic infections

artículo científico publicado en 2000

Reply

Reply

Reproducibility of non-invasive fibrosis biomarkers, FibroMeter and FibroTest, could be improved by respecting the analytical standardizations.

artículo científico publicado en 2008

Response to interferon alpha treatment and disappearance of cryoglobulinaemia in patients infected by hepatitis C virus

artículo científico publicado en 1999

Results transferability on RXL, ARX, X-Pand, BN2 (Dade Behring) and modular DP (Roche Diagnostics) analysers: application to component assays of fibrotest and Actitest

artículo científico publicado en 2005

Review article: Overview of medical treatments in unresectable hepatocellular carcinoma--an impossible meta-analysis?

artículo científico publicado en 1998

Review article: an unexpected virus-host interaction--the hepatitis C virus-diabetes link

artículo científico publicado en 2005

Review article: critical review of meta-analyses of randomized clinical trials in hepatogastroenterology

artículo científico publicado en 1997

Risk of hepatic vein thrombosis in relation to recent use of oral contraceptives. A case-control study

scholarly article by D Valla et al published April 1986 in Gastroenterology

Role of genotype G hepatitis B virus mixed infection on the progression of hepatic fibrosis in HIV positive patients over 5 years of follow-up

artículo científico publicado en 2013

Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial

artículo científico publicado en 2008

Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study

artículo científico publicado en 2001

Safety and efficacy of adefovir dipivoxil in patients infected with lamivudine-resistant hepatitis B and HIV-1.

artículo científico publicado en 2005

Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report

artículo científico publicado en 2000

Sampling Variability of Liver Biopsy in Nonalcoholic Fatty Liver Disease

artículo científico publicado en 2005

Sarcoidosis and interferon therapy: report of five cases and review of the literature

artículo científico publicado en 2003

Screening for liver disease using non-invasive biomarkers (FibroTest, SteatoTest and NashTest) in patients with hyperlipidaemia

artículo científico publicado en 2007

Screening for liver fibrosis by using a noninvasive biomarker in patients with diabetes.

artículo científico publicado en 2008

Sequential combination of glucocorticosteroids and alfa interferon versus alfa interferon alone for HBeAg-positive chronic hepatitis B

artículo científico publicado en 2005

Serial passage of West-European sporadic non-A non-B hepatitis in rhesus monkeys by inoculation with fecal extracts

scientific article published on 01 January 1990

Serum apolipoprotein A-I in alcoholic patients with chronic calcifying pancreatitis

artículo científico publicado en 1990

Serum apolipoprotein A1 and haptoglobin, in patients with suspected drug-induced liver injury (DILI) as biomarkers of recovery

artículo científico publicado en 2017

Serum biochemical markers accurately predict liver fibrosis in HIV and hepatitis C virus co-infected patients

artículo científico publicado en 2003

Severe acute pancreatitis related to the use of nelfinavir in HIV infection: report of a case with positive rechallenge

article

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity

artículo científico publicado en 1998

Slow regression of liver fibrosis presumed by repeated biomarkers after virological cure in patients with chronic hepatitis C

artículo científico publicado en 2013

Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study

artículo científico publicado en 2015

Spleen stiffness measurement by transient elastography to diagnose portal hypertension in children

artículo científico publicado en 2014

Spontaneous ascitic fluid infection and bacteremia due to Yersinia pseudotuberculosis in a liver transplant patient

artículo científico publicado en 2015

Staging chronic hepatitis B into seven categories, defining inactive carriers and assessing treatment impact using a fibrosis biomarker (FibroTest®) and elastography (FibroScan®).

artículo científico publicado en 2014

Staging chronic hepatitis C in seven categories using fibrosis biomarker (FibroTest™) and transient elastography (FibroScan®).

artículo científico publicado en 2013

Standardization of ROC Curve Areas for Diagnostic Evaluation of Liver Fibrosis Markers Based on Prevalences of Fibrosis Stages

artículo científico publicado en 2007

Statins, antidiabetic medications and liver histology in patients with diabetes with non-alcoholic fatty liver disease

artículo científico publicado en 2016

Stéatohépatite métabolique : 30 ans de recherches qui ont changé la NASH

artículo científico publicado en 2009

Successful ablation of a large fibrovascular polyp of the esophagus by endoscopic Nd:YAG laser therapy

artículo científico publicado en 1989

Successful control of subfulminant hepatitis related to lamivudine-resistant hepatitis B virus in an HIV-infected patient

artículo científico publicado en 2001

Successful rescue therapy with tenofovir in a patient with hepatic decompensation and adefovir resistant HBV mutant

artículo científico publicado en 2006

Summary of the first international symposium on viral hepatitis

artículo científico publicado en 1999

Survival and prognostic factors in patients with severe alcoholic hepatitis treated with prednisolone

scientific article published on 01 June 1996

Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis

artículo científico publicado en 2002

Systematic review with meta-analysis: direct comparisons of biomarkers for the diagnosis of fibrosis in chronic hepatitis C and B

artículo científico publicado en 2016

Terlipressin in patients with cirrhosis and type 1 hepatorenal syndrome: a retrospective multicenter study

artículo científico publicado en 2002

The Risk of Multiplying Diagnostic Combinations in the Absence of a Perfect Gold Standard For a Fibrosis Test

artículo científico publicado en 2011

The burden cost of French patients suffering from irritable bowel syndrome.

artículo científico publicado en 2004

The diagnostic value of biomarkers (AshTest) for the prediction of alcoholic steato-hepatitis in patients with chronic alcoholic liver disease

The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis

artículo científico publicado en 2005

The diagnostic value of combining carbohydrate-deficient transferrin, fibrosis, and steatosis biomarkers for the prediction of excessive alcohol consumption

artículo científico publicado en 2009

The elusiveness of "normal" ALT in fatty liver

artículo científico publicado en 2004

The impact of interferon plus ribavirin on response to therapy in black patients with chronic hepatitis C. The International Hepatitis Interventional Therapy Group

artículo científico publicado en 2000

The impact of prior hepatitis B virus infection on liver histology and the response to interferon therapy in chronic hepatitis C.

artículo científico publicado en 2003

The new paradigm of hepatitis C therapy: integration of oral therapies into best practices

artículo científico publicado en 2013

The predictive value of Fibrotest vs. APRI for the diagnosis of fibrosis in chronic hepatitis C.

artículo científico publicado en 2004

The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C.

artículo científico publicado en 2003

The renal tolerance of low-dose adefovir dipivoxil by lamivudine-resistant individuals co-infected with hepatitis B and HIV.

artículo científico publicado en 2004

The risks of changing the rules for previously validated biomarkers and using the same patients several times. Response letter to Calès et al. Gastroenterol Clin Biol 2008;32:1050–60: “Evaluation and improvement of a reliable diagnosis of cirrho

artículo científico publicado en 2009

The role of interleukin-10 in severe acute alcoholic hepatitis

artículo científico publicado en 2001

The use of transient elastography and non-invasive serum markers of fibrosis in pediatric liver transplant recipients

artículo científico publicado en 2013

Touching some firm ground in the epidemiology of NASH

artículo científico publicado en 2011

Transforming growth factor beta 1: in situ expression in the liver of patients with chronic hepatitis C treated with alpha interferon

artículo científico publicado en 1993

Transforming growth factor—beta 1 (TGF-β1) and TGF-β1 receptors in normal, cirrhotic, and neoplastic human livers

article published in 1995

Transjugular intrahepatic portosystemic shunts: comparison with paracentesis in patients with cirrhosis and refractory ascites: a randomized trial

artículo científico publicado en 1996

Treatment and prevention of hepatitis C

artículo científico publicado en 2000

Treatment of chronic hepatitis B virus infection in patients co-infected with human immunodeficiency virus

artículo científico publicado en 2003

Treatment of cirrhotic patients in the pegylated interferon era.

artículo científico publicado en 2004

Treatment of gastroesophageal reflux: analysis of randomized double-blind trials

artículo científico publicado en 1987

Treatment of hepatitis C virus: the first decade

artículo científico publicado en 2004

Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890.

artículo científico publicado en 2013

Une hépatite à cytomégalovirus n’est jamais chronique, et peut en cacher une autre !

artículo científico publicado en 2001

Unsuccessful rescue therapy with adefovir dipivoxil for lamivudine resistant HBV in a patient with liver failure

artículo científico publicado en 2003

Upper digestive tract hemorrhage in cirrhotic patients. Contribution of multidimensional analysis to the study of variables related to the cause of the hemorrhage.

artículo científico publicado en 1981

Ursodeoxycholic acid for the treatment of primary biliary cirrhosis. Interim analysis of a double-blind multicentre randomized trial. The UDCA-PBC Study Group.

artículo científico publicado en 1990

Validation of AshTest as a Non-Invasive Alternative to Transjugular Liver Biopsy in Patients with Suspected Severe Acute Alcoholic Hepatitis

artículo científico publicado en 2015

Validation of liver fibrosis biomarker (FibroTest) for assessing liver fibrosis progression: Proof of concept and first application in a large population

scientific article published on 18 May 2012

Variability in definitions of transaminase upper limit of the normal impacts the APRI performance as a biomarker of fibrosis in patients with chronic hepatitis C: "APRI c'est fini ?".

artículo científico publicado en 2014

Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation

artículo científico publicado en 2007

Viral hepatitis B.

artículo científico publicado en 2003

Viral hepatitis C.

artículo científico publicado en 2003

Weak immunogenicity of the preS2 sequence and lack of circumventing effect on the unresponsiveness to the hepatitis B virus vaccine

artículo científico publicado en 1995

What are the best reference values for a normal serum alanine transaminase activity (ALT)? Impact on the presumed prevalence of drug induced liver injury (DILI)

artículo científico publicado en 2011

What are the indications for treatment of acute hepatitis C?

artículo científico publicado en 2002

Worsening of steatosis and fibrosis progression

artículo científico publicado en 2003

[Acute tuberculous pancreatitis in a patient with acquired immunodeficiency syndrome]

artículo científico publicado en 1990

Évaluation non-invasive de la fibrose hépatique au cours de l’hépatite C

artículo científico publicado en 2008

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda